Other Assets, Current of ACCENDRA HEALTH INC/VA/ from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
ACCENDRA HEALTH INC/VA/ quarterly Other Assets, Current in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • ACCENDRA HEALTH INC/VA/ Other Assets, Current for the quarter ending 30 Sep 2025 was $68,129,000, a 59% decline year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $68,129,000 -$98,838,000 -59% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $104,011,000 -$85,531,000 -45% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $158,048,000 -$18,972,000 -11% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $82,240,000 -$68,650,000 -45% 31 Dec 2024 10-Q 31 Oct 2025 2025 Q3
Q3 2024 $166,967,000 +$18,921,000 +13% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $189,542,000 +$54,133,000 +40% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $177,020,000 +$21,623,000 +14% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $150,890,000 +$22,254,000 +17% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $148,046,000 +$43,312,000 +41% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $135,409,000 +$26,797,000 +25% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $155,397,000 +$36,508,000 +31% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $128,636,000 +$40,072,000 +45% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $104,734,000 +$20,399,000 +24% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $108,612,000 +$20,903,000 +24% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $118,889,000 +$25,681,000 +28% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $88,564,000 -$29,700,000 -25% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $84,335,000 -$151,648,000 -64% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $87,709,000 -$87,535,000 -50% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $93,208,000 -$58,427,000 -39% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $118,264,000 +$38,892,000 +49% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $235,983,000 -$23,725,000 -9.1% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $175,244,000 -$126,990,000 -42% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $151,635,000 -$184,430,000 -55% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $79,372,000 -$42,554,000 -35% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $259,708,000 -$34,285,000 -12% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $302,234,000 -$17,972,000 -5.6% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $336,065,000 +$35,790,000 +12% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $121,926,000 -$206,328,000 -63% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 $293,993,000 -$17,506,000 -5.6% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 $320,206,000 +$13,754,000 +4.5% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $300,275,000 +$39,043,000 +15% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $328,254,000 +$74,098,000 +29% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $311,499,000 +$27,746,000 +9.8% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 $306,452,000 +$37,807,000 +14% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $261,232,000 -$8,466,000 -3.1% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 $254,156,000 -$30,814,000 -11% 31 Dec 2016 10-K 23 Feb 2018 2017 FY
Q3 2016 $283,753,000 +$17,995,000 +6.8% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $268,645,000 -$6,836,000 -2.5% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 $269,698,000 +$36,380,000 +16% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 $284,970,000 -$29,509,000 -9.4% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $265,758,000 -$29,683,000 -10% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $275,481,000 -$12,363,000 -4.3% 30 Jun 2015 10-Q 28 Jul 2015 2015 Q2
Q1 2015 $233,318,000 -$41,861,000 -15% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 $314,479,000 +$34,969,000 +13% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $295,441,000 +$49,199,000 +20% 30 Sep 2014 10-Q 29 Oct 2014 2014 Q3
Q2 2014 $287,844,000 +$39,625,000 +16% 30 Jun 2014 10-Q 30 Jul 2014 2014 Q2
Q1 2014 $275,179,000 +$69,837,000 +34% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 $279,510,000 +$48,246,000 +21% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 $246,242,000 +$34,275,000 +16% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $248,219,000 +$175,873,000 +243% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 $205,342,000 +$138,695,000 +208% 31 Mar 2013 10-Q 03 May 2013 2013 Q1
Q4 2012 $231,264,000 +$154,501,000 +201% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q3 2012 $211,967,000 +$147,407,000 +228% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 $72,346,000 +$1,746,000 +2.5% 30 Jun 2012 10-Q 27 Jul 2012 2012 Q2
Q1 2012 $66,647,000 +$9,497,000 +17% 31 Mar 2012 10-Q 27 Apr 2012 2012 Q1
Q4 2011 $76,763,000 +$23,964,000 +45% 31 Dec 2011 10-K 22 Feb 2013 2012 FY
Q3 2011 $64,560,000 +$15,148,000 +31% 30 Sep 2011 10-Q 28 Oct 2011 2011 Q3
Q2 2011 $70,600,000 +$16,483,000 +30% 30 Jun 2011 10-Q 29 Jul 2011 2011 Q2
Q1 2011 $57,150,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 $52,799,000 31 Dec 2010 10-K 24 Feb 2012 2011 FY
Q3 2010 $49,412,000 30 Sep 2010 10-Q 29 Oct 2010 2010 Q3
Q2 2010 $54,117,000 30 Jun 2010 10-Q 30 Jul 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.